127 related articles for article (PubMed ID: 1350487)
21. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
22. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
[TBL] [Abstract][Full Text] [Related]
26. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
Widmann L; van der Does R; Hörrmann M; Machwirth M
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
[TBL] [Abstract][Full Text] [Related]
27. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
28. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
29. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
30. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
Omvik P; Lund-Johansen P; Myking O
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
[TBL] [Abstract][Full Text] [Related]
31. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
Forrest EH; Bouchier IA; Hayes PC
J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
[TBL] [Abstract][Full Text] [Related]
32. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
33. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
34. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
[TBL] [Abstract][Full Text] [Related]
35. [Severe pulmonary hypertensión treated with low dose carvedilol in a patient infected with the human immunodeficiency virus].
Eulalia Valencia M; Guinea J; Moreno V; González-Lahoz J
Enferm Infecc Microbiol Clin; 2001 Oct; 19(8):412-3. PubMed ID: 11602149
[No Abstract] [Full Text] [Related]
36. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
37. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
Dupont AG; Schoors DF; Venuti RP
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
[TBL] [Abstract][Full Text] [Related]
38. Controlled-release carvedilol in the treatment of essential hypertension.
Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
40. [Effects of carvedilol on the hemodynamics and its tolerance in elderly patients].
Asai T; Kuzuya M; Koike A; Kanda S; Maeda K; Iguchi A
Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):187-92. PubMed ID: 11974943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
